Holen Sie sich die Stockscreener-App
47.30
0.19%
-0.09
Handel nachbörslich:
47.35
0.05
+0.11%
Schlusskurs vom Vortag:
$47.39
Offen:
$47.6
24-Stunden-Volumen:
2.78M
Relative Volume:
0.52
Marktkapitalisierung:
$8.46B
Einnahmen:
$1.27B
Nettoeinkommen (Verlust:
$-245.03M
KGV:
-33.62
EPS:
-1.4071
Netto-Cashflow:
$-245.36M
1W Leistung:
+11.64%
1M Leistung:
-9.49%
6M Leistung:
-49.18%
1J Leistung:
+11.09%
1-Tages-Spanne:
$47.27
$48.46
1-Wochen-Bereich:
$43.00
$48.46
52-Wochen-Spanne:
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
47.30 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
174.64 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
43.51 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
83.44 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.63 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Artificial Intelligence Stocks To Watch TodayApril 6th - marketbeat.com
Buy Signal: How does Tempus AI Inc correlate with Nasdaq2026 Short Interest & Expert Curated Trade Setups - baoquankhu1.vn
Signal Recap: Whats next for Tempus AI Inc stock2026 Movers & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Tempus AI, Inc. (NASDAQ:TEM) Q1 2025 Earnings Call Transcript - MSN
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares - AOL.com
Top Artificial Intelligence Stocks To Watch NowApril 5th - marketbeat.com
Tempus AI: A Stock Caught Between Institutional Backing and Market Skepticism - AD HOC NEWS
Best Artificial Intelligence Stocks To Add to Your WatchlistApril 4th - marketbeat.com
Tempus AI, Inc. (TEM) stock price, news, quote and history - Yahoo Finance UK
Best Artificial Intelligence Stocks To Keep An Eye OnApril 3rd - MarketBeat
Tempus AI: A Dual-Engine AI Model - Seeking Alpha
Tempus, Medtronic find AI alert tool can improve cardiac valve care - Crain's Chicago Business
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tempus AI Stock Gains Following the ALERT Trial Result Announcement - TradingView
Suits Against Tempus AI Test Legal Lines for Mining Genetic Data - Law.com
DLD Asset Management, LP's Tempus AI Inc(TEM) Holding History - gurufocus.com
Assessing Tempus AI (TEM) Valuation After ALERT Cardiology Trial Results And Expanded Merck Collaboration - Yahoo Finance
Tempus AI: 450-Petabyte Moat, High-Growth Upside At A Discount (NASDAQ:TEM) - Seeking Alpha
Can Tempus AI’s (TEM) ALERT Trial Quietly Redefine Its Real-World Data Advantage in Cardiology? - Yahoo Finance
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease - 01net
What's Fueling TEM Diagnostics Segment's Strong 2026 Outlook? - Yahoo Finance Singapore
Tempus AI Stock Jumps, ALERT Trial Results Boost EHR Automation BuzzTempus AI (NASDAQ:TEM) - Benzinga
Tempus AI, Inc. Announces Results from ALERT Trial - marketscreener.com
Tempus AI, Medtronic Report Positive Clinical Trial Results for Medical Alert System - MarketScreener
Tempus and Medtronic announce alert trial results showing AI-driven EHR notifications improve treatment for significant valvular heart disease - marketscreener.com
Tempus And Medtronic Announce Alert Trial Results Showing Ai-Driven Ehr Notifications Improve Treatment For Significant Valvular Heart Disease - TradingView
Tempus AI trial shows automated alerts improve heart valve care By Investing.com - Investing.com India
Tempus AI trial shows automated alerts improve heart valve care - Investing.com
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now? - The Globe and Mail
Jim Cramer on Tempus AI: “It’s a Decent Spec, I Would Hold on to Some, But Not All” - Insider Monkey
Hims & Hers Expands Personalized Digital Healthcare Platform - TradingView
2 AI Healthcare Stocks to Buy Right Now - The Globe and Mail
Tempus AI, Inc.Class A Common Stock (NQ: TEM - FinancialContent
Tempus AI: An Attractive Entry Point At Current Prices (NASDAQ:TEM) - Seeking Alpha
Tempus AI (TEM) Analyst Rating Update: Guggenheim Lowers Price T - GuruFocus
Buy, sell, or hold? Jim Cramer’s take on 18 callers’ stocks as crude oil prices climb - MSN
Guggenheim Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat
Guggenheim Maintains Tempus AI(TEM.US) With Buy Rating, Cuts Target Price to $60 - Moomoo
Tempus AI Insider Sold Shares Worth $7,711,150, According to a Recent SEC Filing - MarketScreener
Top Artificial Intelligence Stocks To Follow TodayMarch 29th - marketbeat.com
TEM Stock Quote Price and Forecast - CNN
Artificial Intelligence Stocks To Keep An Eye OnMarch 28th - marketbeat.com
Is Tempus AI’s (TEM) Oncology Data Push Quietly Redefining Its Long-Term Moat? - simplywall.st
Eric Lefkofsky Sells 166,250 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Lightning round: Tempus AI is a 'decent spec', says Jim Cramer - MSN
# Lefkofsky Eric P, CEO of Tempus AI, sells $7.7 million in stock - Investing.com India
Tempus AI (TEM) CEO-linked entities sell 166K shares under 10b5-1 plan - Stock Titan
Tempus AI Inc. (TEM) touted as a buy amid focus on healthcare opportunities - MSN
Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI - Mugglehead Magazine
Artificial Intelligence Stocks To ConsiderMarch 27th - MarketBeat
Vanguard disaggregates holdings; reports 0 shares of Tempus AI (TEM) - stocktitan.net
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):